Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Vestibular CCK signaling drives motion sickness-like behavior in mice

  • Machuca Márquez, Pablo|||0000-0002-7980-3839
  • Sánchez Benito, Laura
  • Menardy, Fabien Louis Joseph|||0000-0002-8712-1344
  • Urpi, Andrea|||0000-0002-2437-7094
  • Girona, Mònica
  • Puighermanal Puigvert, Emma|||0000-0003-4271-9104
  • Appiah, Isabella|||0000-0002-4684-4992
  • Palmiter, Richard D.|||0000-0001-6587-0582
  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Quintana Romero, Albert|||0000-0003-1674-7160
We live in an age where travel is paramount. However, one of the most disabling conditions inherent to traveling is motion sickness (MS). While studies have underscored the role of the vestibular system in the development of MS, the neuronal populations involved in motion-induced malaise remain largely unknown. Here, we describe the vestibular pathways eliciting MS responses and identify a key role for cholecystokinin (CCK)-expressing vestibular neurons. We reveal that a vestibulo-parabrachial (VN-PBN) CCKergic projection is sufficient to induce conditioned taste avoidance, likely through the activation of calcitonin gene-related peptide-expressing PBN neurons. Finally, we underscore the role of CCK-A receptor signaling as a druggable target to treat MS, providing insight on the neurobiological substrates of MS. Travel can induce motion sickness (MS) in susceptible individuals. MS is an evolutionary conserved mechanism caused by mismatches between motion-related sensory information and past visual and motion memory, triggering a malaise accompanied by hypolocomotion, hypothermia, hypophagia, and nausea. Vestibular nuclei (VN) are critical for the processing of movement input from the inner ear. Motion-induced activation of VN neurons recapitulates MS-related signs. However, the genetic identity of VN neurons mediating MS-related autonomic and aversive responses remains unknown. Here, we identify a central role of cholecystokinin (CCK)-expressing VN neurons in motion-induced malaise. Moreover, we show that CCK VN inputs onto the parabrachial nucleus activate Calca -expressing neurons and are sufficient to establish avoidance to novel food, which is prevented by CCK-A receptor antagonism. These observations provide greater insight into the neurobiological regulation of MS by identifying the neural substrates of MS and providing potential targets for treatment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models

  • Puighermanal Puigvert, Emma|||0000-0003-4271-9104
  • Luna Sánchez, Marta|||0000-0002-1315-3191
  • Gella, Alejandro|||0000-0002-3983-1392
  • Walt, Gunter van der|||0000-0001-5383-439X
  • Urpi, Andrea|||0000-0002-2437-7094
  • Royo, Maria|||0000-0003-3289-2624
  • Tena-Morraja, Paula
  • Appiah, Isabella|||0000-0002-4684-4992
  • Donato, Maria Helena de|||0009-0002-3602-3848
  • Menardy, Fabien Louis Joseph|||0000-0002-8712-1344
  • Bianchi, Patrizia|||0000-0003-3906-9104
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Rodríguez-Pascau, Laura
  • Vergara, Cristina
  • Gómez-Pallarès, Mercè|||0009-0007-7323-734X
  • Marsicano, Giovanni
  • Bellocchio, Luigi
  • Martinell, Marc
  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Jurado, Sandra
  • Soriano, Francesc Xavier
  • Pizcueta, Pilar
  • Quintana Romero, Albert|||0000-0003-1674-7160
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial Proteome of Affected Glutamatergic Neurons in a Mouse Model of Leigh Syndrome

  • Gella, Alejandro
  • Prada-Dacasa, Patricia
  • Carrascal, Montserrat
  • Urpi, Andrea
  • González-Torres, Melania
  • Abián, Joaquín
  • Sanz, Elisenda
  • Quintana, Albert
Defects in mitochondrial function lead to severe neuromuscular orphan pathologies known as mitochondrial disease. Among them, Leigh Syndrome is the most common pediatric presentation, characterized by symmetrical brain lesions, hypotonia, motor and respiratory deficits, and premature death. Mitochondrial diseases are characterized by a marked anatomical and cellular specificity. However, the molecular determinants for this susceptibility are currently unknown, hindering the efforts to find an effective treatment. Due to the complex crosstalk between mitochondria and their supporting cell, strategies to assess the underlying alterations in affected cell types in the context of mitochondrial dysfunction are critical. Here, we developed a novel virus-based tool, the AAV-mitoTag viral vector, to isolate mitochondria from genetically defined cell types. Expression of the AAV-mitoTag in the glutamatergic vestibular neurons of a mouse model of Leigh Syndrome lacking the complex I subunit Ndufs4 allowed us to assess the proteome and acetylome of a subset of susceptible neurons in a well characterized model recapitulating the human disease. Our results show a marked reduction of complex I N-module subunit abundance and an increase in the levels of the assembly factor NDUFA2. Transiently associated non-mitochondrial proteins such as PKCδ, and the complement subcomponent C1Q were also increased in Ndufs4-deficient mitochondria. Furthermore, lack of Ndufs4 induced ATP synthase complex and pyruvate dehydrogenase (PDH) subunit hyperacetylation, leading to decreased PDH activity. We provide novel insight on the pathways involved in mitochondrial disease, which could underlie potential therapeutic approaches for these pathologies., This work was supported by a Marie Skłodowska-Curie COFUND action (H2020-MSCA-COFUND-2014-665919; AG), a Marie Skłodowska-Curie Individual Fellowship (H2020-MSCA-IF-2014-658352; ES), pre-doctoral fellowships (BES-2015-073041 to PP-D; 2018FI_B 00452 to AU), and a Ramón y Cajal fellowship (RyC-2012-11873; AQ). The Proteomics Laboratory CSIC/UAB is a member of Proteored, PRB3-ISCIII, and is supported by Grant PT17/0019/0008, funded by ISCIII and FEDER. ES received funds from MICIU Proyectos I+D+i “Retos Investigacion” (RTI2018-101838-J-I00). AQ received funds from the European Research Council (Starting grant NEUROMITO, ERC-2014-StG-638106), MINECO Proyectos I+D de Excelencia (SAF2014-57981P and SAF2017-88108-R), and AGAUR (2017SGR-323).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models

  • Puighermanal, Emma
  • Luna Sánchez, Marta
  • Gella, Alejandro
  • van der Walt, Gunter
  • Urpi, Andrea
  • Royo, María
  • Tena-Morraja, Paula
  • Appiah, Isabella
  • de Donato, María Helena
  • Menardy, Fabien
  • Bianchi, Patrizia
  • Esteve-Codina, Anna
  • Rodríguez-Pascau, Laura
  • Vergara, Cristina
  • Gómez-Pallarès, Mercè
  • Marsicano, Giovanni
  • Bellocchio, Luigi
  • Martinell, Marc
  • Sanz, Elisenda
  • Jurado, Sandra
  • Soriano, Francesc Xavier
  • Pizcueta, Pilar
  • Quintana, Albert
Mutations in mitochondrial energy-producing genes lead to a heterogeneous group of untreatable disorders known as primary mitochondrial diseases (MD). Leigh syndrome (LS) is the most common pediatric MD and is characterized by progressive neuromuscular affectation and premature death. Here, we show that daily cannabidiol (CBD) administration significantly extends lifespan and ameliorates pathology in two LS mouse models, and improves cellular function in fibroblasts from LS patients. CBD delays motor decline and neurodegenerative signs, improves social deficits and breathing abnormalities, decreases thermally induced seizures, and improves neuropathology in affected brain regions. Mechanistically, we identify peroxisome proliferator-activated receptor gamma (PPARγ) as a key nuclear receptor mediating CBD's beneficial effects, while also providing proof of dysregulated PPARγ expression and activity as a common feature in both mouse neurons and fibroblasts from LS patients. Taken together, our results provide the first evidence for CBD as a potential treatment for LS., This work was supported by three MINECO Ramon y Cajal fellowships (RYC2020-029596-I; E.P., RYC2019-028501-I; E.S., and RyC-2012-11873; A.Q.), a Beatriu de Pinós fellowship from University and Research Grants Catalan Management Agency (#2017BP00132; E.P.) Marie Sklodowska-Curie Individual Fellowship (H2020-MSCA-IF-2014-658352; E.S., H2020-MSCA-IF-2020-101030783, M.L-S., H2020-MSCA-COFUND-2014-665919, A.G.), pre-doctoral fellowships (2018FI_B 00452 to AU, 2024 FI-1 00645 to GvdW). E.P received funds from MICINN (PID2021-125079OA-I00). E.S received funds from MICIU Proyectos I + D + i “Retos Investigacion” (RTI2018-101838-J-I00) and Ministerio de Ciencia e Innovación (MICINN) (PID2019-107633RB-I00 and PID2022-142544OB-I00). A.Q. is a recipient of an ICREA Academia award and received funds from the European Research Council (Starting grant NEUROMITO, ERC-2014-StG-638106), Grants SAF2014-57981P; SAF2017-88108-R, PID2020-114977RB-I00, RTC2019-006825-1, PDC2021-121883-I0, RED2022-134786-T, funded by MICIU/AEI /10.13039/5011000110330 and by MICIU/AEI /10.13039/501100011033 and Next GenerationEU/ PRTR, AGAUR (2017SGR-323, 2021SGR-720), Fundació TV3-La Marató (202030), and “la Caixa” Foundation (ID 100010434), under the agreement LCF/PR/HR20/52400018., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Agouti-related peptide neural circuits mediate adaptive behaviors in the starved state

  • Padilla, Stephanie L.
  • Qiu, Jian
  • Soden, Marta E.
  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Nestor, Casey C.
  • Barker, Forrest D.
  • Quintana Romero, Albert|||0000-0003-1674-7160
  • Zweifel, Larry S.
  • Rønnekleiv, Oline K.
  • Kelly, Martin J.
  • Palmiter, Richard D.|||0000-0001-6587-0582
In the face of starvation, animals will engage in high-risk behaviors that would normally be considered maladaptive. Starving rodents, for example, will forage in areas that are more susceptible to predators and will also modulate aggressive behavior within a territory of limited or depleted nutrients. The neural basis of these adaptive behaviors likely involves circuits that link innate feeding, aggression and fear. Hypothalamic agouti-related peptide (AgRP)-expressing neurons are critically important for driving feeding and project axons to brain regions implicated in aggression and fear. Using circuit-mapping techniques in mice, we define a disynaptic network originating from a subset of AgRP neurons that project to the medial nucleus of the amygdala and then to the principal bed nucleus of the stria terminalis, which suppresses territorial aggression and reduces contextual fear. We propose that AgRP neurons serve as a master switch capable of coordinating behavioral decisions relative to internal state and environmental cues.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Loss of mitochondrial Ndufs4 in striatal medium spiny neurons mediates progressive motor impairment in a mouse model of leigh syndrome

  • Chen, Byron
  • Hui, Jessica
  • Montgomery, Kelsey S.
  • Gella, Alejandro|||0000-0002-3983-1392
  • Bolea Tomás, Irene|||0000-0001-9591-980X
  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Palmiter, Richard D.|||0000-0001-6587-0582
  • Quintana Romero, Albert|||0000-0003-1674-7160
Inability of mitochondria to generate energy leads to severe and often fatal myoencephalopathies. Among these, Leigh syndrome (LS) is one of the most common childhood mitochondrial diseases; it is characterized by hypotonia, failure to thrive, respiratory insufficiency and progressive mental and motor dysfunction, leading to early death. Basal ganglia nuclei, including the striatum, are affected in LS patients. However, neither the identity of the affected cell types in the striatum nor their contribution to the disease has been established. Here, we used a mouse model of LS lacking Ndufs4, a mitochondrial complex I subunit, to confirm that loss of complex I, but not complex II, alters respiration in the striatum. To assess the role of striatal dysfunction in the pathology, we selectively inactivated Ndufs4 in the striatal medium spiny neurons (MSNs), which account for over 95% of striatal neurons. Our results show that lack of Ndufs4 in MSNs causes a non-fatal progressive motor impairment without affecting the cognitive function of mice. Furthermore, no inflammatory responses or neuronal loss were observed up to 6 months of age. Hence, complex I deficiency in MSNs contributes to the motor deficits observed in LS, but not to the neural degeneration, suggesting that other neuronal populations drive the plethora of clinical signs in LS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Striatal GPR88 modulates foraging efficiency

  • Rainwater, Aundrea
  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Palmiter, Richard D.|||0000-0001-6587-0582
  • Quintana Romero, Albert|||0000-0003-1674-7160
The striatum is anatomically and behaviorally implicated in behaviors that promote efficient foraging. To investigate this function, we studied instrumental choice behavior in mice lacking GPR88, a striatum-enriched orphan G-protein-coupled receptor that modulates striatal medium spiny neuron excitability. Our results reveal that hungry mice lacking GPR88 (KO mice) were slow to acquire food-reinforced lever press but could lever press similar to controls on a progressive ratio schedule. Both WT and KO mice discriminated between reward and no-reward levers; however, KO mice failed to discriminate based on relative quantity-reward (1 vs 3 food pellets) or effort (3 vs 9 lever presses). We also demonstrate preference for the high-reward (3 pellet) lever was selectively reestablished when GPR88 expression was restored to the striatum. We propose that GPR88 expression within the striatum is integral to efficient action-selection during foraging.SIGNIFICANCE STATEMENT Evolutionary pressure driving energy homeostasis favored detection and comparison of caloric value. In wild and laboratory settings, neural systems involved in energy homeostasis bias foraging to maximize energy efficiency. This is observed when foraging behaviors are guided by superior nutritional density or minimized caloric expenditure. The striatum is anatomically and functionally well placed to perform the sensory and motor integration necessary for efficient action selection during foraging. However, few studies have examined this behavioral phenomenon or elucidated underlying molecular mechanisms. Both humans and mice with nonfunctional GPR88 have been shown to present striatal dysfunctions and impaired learning. We demonstrate that GPR88 expression is necessary to efficiently integrate effort and energy density information guiding instrumental choice.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

RiboTag, Ribosomal tagging strategy to analyze cell type specific mRNA expression in vivo

  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Bean, Jonathan C.
  • Carey, Daniel P.
  • Quintana Romero, Albert|||0000-0003-1674-7160
  • McKnight, G. Stanley
Ribosome tagging has become a very useful in vivo approach for analyzing gene expression and mRNA translation in specific cell types that are difficult and time consuming to isolate by conventional methods. The approach is based on selectively expressing an HA-tagged ribosomal protein in a target cell type and then using antibodies against HA to purify the polysomes and associated mRNAs from the target cell. The original approach makes use of a mouse line (RiboTag) harboring a modified allele of Rpl22 (Rpl22-HA) that is induced by the action of Cre recombinase. The Rpl22-HA gene can also be introduced into the animal by stereotaxic injections of an AAV-DIO-Rpl22-HA that is then activated in Cre-expressing cells. Both methods for tagging ribosomes facilitate the immunoprecipitation of ribosome bound mRNAs and their analysis by qRT-PCR or RNA-Seq. This protocol will discuss the technical procedures and describe important considerations relevant to the analysis of the data.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Defined neuronal populations drive fatal phenotype in a mouse model of leigh syndrome

  • Bolea Tomás, Irene|||0000-0001-9591-980X
  • Gella, Alejandro|||0000-0002-3983-1392
  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Prada Dacasa, Patricia|||0000-0003-0689-9072
  • Menardy, Fabien Louis Joseph|||0000-0002-8712-1344
  • Bard, Angela M.
  • Machuca Márquez, Pablo|||0000-0002-7980-3839
  • Eraso-Pichot, Abel|||0000-0001-6837-2714
  • Mòdol Caballero, Guillem|||0000-0002-5749-9098
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • Kalume, Frank
  • Quintana Romero, Albert|||0000-0003-1674-7160
Mitochondrial deficits in energy production cause untreatable and fatal pathologies known as mitochondrial disease (MD). Central nervous system affectation is critical in Leigh Syndrome (LS), a common MD presentation, leading to motor and respiratory deficits, seizures and premature death. However, only specific neuronal populations are affected. Furthermore, their molecular identity and their contribution to the disease remains unknown. Here, using a mouse model of LS lacking the mitochondrial complex I subunit Ndufs4, we dissect the critical role of genetically-defined neuronal populations in LS progression. Ndufs4 inactivation in Vglut2expressing glutamatergic neurons leads to decreased neuronal firing, brainstem inflammation, motor and respiratory deficits, and early death. In contrast, Ndufs4 deletion in GABAergic neurons causes basal ganglia inflammation without motor or respiratory involvement, but accompanied by hypothermia and severe epileptic seizures preceding death. These results provide novel insight in the cell type-specific contribution to the pathology, dissecting the underlying cellular mechanisms of MD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mitochondrial Proteome of Affected Glutamatergic Neurons in a Mouse Model of Leigh Syndrome

  • Gella, Alejandro|||0000-0002-3983-1392
  • Prada Dacasa, Patricia|||0000-0003-0689-9072
  • Carrascal Pérez, Montserrat|||0000-0002-0205-2176
  • Urpi, Andrea|||0000-0002-2437-7094
  • González Torres, Melania|||0000-0002-9755-8160
  • Abian, Joaquin|||0000-0003-2823-5429
  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Quintana Romero, Albert|||0000-0003-1674-7160
Defects in mitochondrial function lead to severe neuromuscular orphan pathologies known as mitochondrial disease. Among them, Leigh Syndrome is the most common pediatric presentation, characterized by symmetrical brain lesions, hypotonia, motor and respiratory deficits, and premature death. Mitochondrial diseases are characterized by a marked anatomical and cellular specificity. However, the molecular determinants for this susceptibility are currently unknown, hindering the efforts to find an effective treatment. Due to the complex crosstalk between mitochondria and their supporting cell, strategies to assess the underlying alterations in affected cell types in the context of mitochondrial dysfunction are critical. Here, we developed a novel virus-based tool, the AAV-mitoTag viral vector, to isolate mitochondria from genetically defined cell types. Expression of the AAV-mitoTag in the glutamatergic vestibular neurons of a mouse model of Leigh Syndrome lacking the complex I subunit Ndufs4 allowed us to assess the proteome and acetylome of a subset of susceptible neurons in a well characterized model recapitulating the human disease. Our results show a marked reduction of complex I N-module subunit abundance and an increase in the levels of the assembly factor NDUFA2. Transiently associated non-mitochondrial proteins such as PKCδ, and the complement subcomponent C1Q were also increased in Ndufs4 -deficient mitochondria. Furthermore, lack of Ndufs4 induced ATP synthase complex and pyruvate dehydrogenase (PDH) subunit hyperacetylation, leading to decreased PDH activity. We provide novel insight on the pathways involved in mitochondrial disease, which could underlie potential therapeutic approaches for these pathologies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mitochondria-induced immune response as a trigger for neurodegeneration, A pathogen from within

  • Luna Sánchez, Marta
  • Bianchi, Patrizia
  • Quintana Romero, Albert|||0000-0003-1674-7160
Symbiosis between the mitochondrion and the ancestor of the eukaryotic cell allowed cellular complexity and supported life. Mitochondria have specialized in many key functions ensuring cell homeostasis and survival. Thus, proper communication between mitochondria and cell nucleus is paramount for cellular health. However, due to their archaebacterial origin, mitochondria possess a high immunogenic potential. Indeed, mitochondria have been identified as an intracellular source of molecules that can elicit cellular responses to pathogens. Compromised mitochondrial integrity leads to release of mitochondrial content into the cytosol, which triggers an unwanted cellular immune response. Mitochondrial nucleic acids (mtDNA and mtRNA) can interact with the same cytoplasmic sensors that are specialized in recognizing genetic material from pathogens. High-energy demanding cells, such as neurons, are highly affected by deficits in mitochondrial function. Notably, mitochondrial dysfunction, neurodegeneration, and chronic inflammation are concurrent events in many severe debilitating disorders. Interestingly in this context of pathology, increasing number of studies have detected immune-activating mtDNA and mtRNA that induce an aberrant production of pro-inflammatory cytokines and interferon effectors. Thus, this review provides new insights on mitochondria-driven inflammation as a potential therapeutic target for neurodegenerative and primary mitochondrial diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Microglial response promotes neurodegeneration in the Ndufs4 KO mouse model of Leigh syndrome

  • Aguilar Ludwig, Kevin|||0000-0002-1452-2841
  • Comes, Gemma|||0000-0002-4074-7665
  • Canal Capdevila, Carla|||0000-0002-2150-4836
  • Quintana Romero, Albert|||0000-0003-1674-7160
  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Hidalgo Pareja, Juan|||0000-0003-0921-1122
Leigh syndrome is a mitochondrial disease characterized by neurodegeneration, neuroinflammation, and early death. Mice lacking NDUFS4, a mitochondrial complex I subunit (Ndufs4 KO mice), have been established as a good animal model for studying human pathology associated with Leigh syndrome. As the disease progresses, there is an increase in neurodegeneration and neuroinflammation, thereby leading to deteriorating neurological symptoms, including motor deficits, breathing alterations, and eventually, death of the animal. However, despite the magnitude of neuroinflammation associated with brain lesions, the role of neuroinflammatory pathways and their main cellular components have not been addressed directly as relevant players in the disease pathology. Here, we investigate the role of microglial cells, the main immune cells of the CNS, in Leigh-like syndrome pathology, by pharmacologically depleting them using the colony-stimulating factor 1 receptor antagonist PLX3397. Microglial depletion extended lifespan and delayed motor symptoms in Ndufs4 KO mice, likely by preventing neuronal loss. Next, we investigated the role of the major cytokine interleukin-6 (IL-6) in the disease progression. IL-6 deficiency partially rescued breathing abnormalities and modulated gliosis but did not extend the lifespan or rescue motor decline in Ndufs4 KO mice. The present results show that microglial accumulation is pathogenic, in a process independent of IL-6, and hints toward a contributing role of neuroinflammation in the disease of Ndufs4 KO mice and potentially in patients with Leigh syndrome.